Non-Coding RNA NEAT1/miR-214-3p Contribute to Doxorubicin Resistance of Urothelial Bladder Cancer Preliminary Through the Wnt/β-Catenin pathway [Retraction]

Guo Y, Zhang H, Xie D, Hu X, Song R, Zhu L. Cancer Manag Res. 2018;10:4371-4380.

The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised regarding the alleged duplication of western blot bands in Figure 2 with those from another unrelated article. Specifically,

• Figure 2F, bands P-gp, appear to have been duplicated with the same bands from Figure 5F, p-AKT in Yang et al, 2018 (https://doi.org/10.3389/fnmol.2017.00437).

In addition, western blots bands from Figure 5 also appear to have been duplicated. Specifically,

• Figure 5B, bands J82/DOX, GAPDH, appear to have been duplicated with the same bands from Figure 5B, T24/DOX, GAPDH.

There were also unexpected similarities found between the flow cytometry images shown in Figures 4E and 4F.

The authors responded to our queries but were unable to provide an adequate explanation for the duplicated images, nor were they able to provide the original data for their study. The Editor determined the findings of the study were unreliable and requested to retract the article. The authors agreed with this decision.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.